Author(s): Leena Sawaikar, Pankaj Kapupara

Email(s): sawaikarleena@gmail.com

DOI: 10.5958/0974-360X.2020.00427.8   

Address: Leena Sawaikar1,2, Pankaj Kapupara3
1PES’s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi – Ponda, Goa.
2Research Scholar, R K University, Bhavnagar Highway, Kasturbadham, Rajkot – 360020 Gujarat, India.
3School of Pharmacy, R K University, Bhavnagar Highway, Kasturbadham, Rajkot – 360020 Gujarat, India.
*Corresponding Author

Published In:   Volume - 13,      Issue - 5,     Year - 2020


ABSTRACT:
A simple and a rapid stability indicating RP-HPLC method has been developed for the estimation of Chlorthalidone and Cilnidipine in their combined dosage form. The separation was achieved on waters C18 column, (100mm x 4.6mm, 2.5µm) using a mobile phase consisting of phase A, (0.1 %Formic acid in methanol : Acetonitrile in the ratio 80:20 v/v) phase B, (10 mM ammonium acetate) in gradient mode, at aflow rate of 1.0mL/min. The wavelength selected for detection was 240 nm and a PDA detector was employed for the detection. The retention time of Chlorthalidone was 6.047±0.2 min and Cilnidipine was 12.642 ±0.2 min. The developed method was validated for specificity, linearity, accuracy precision and robustness. There was no interference seen in the blank at the retention time of the drugs hence the method was specific. The linear regression seen in calibration curve of both the drugs was 0.999. The mean percent recovery of Chlorthalidone and Cilnidipine was within the acceptance criteria. Both the drugs were subjected to a variety of stress environment which included acid, base, peroxide, UV radiations and heat. It was observed that the peaks of the degradants of both the drugs could be well resolved from that of pure drugs. The proposed method can be used for rapid quantification and simultaneous analysis of both drugs from commercial formulations without any interference.


Cite this article:
Leena Sawaikar, Pankaj Kapupara. Development and Validation of a Stability indicating RP-HPLC Method for the Estimation of Chlorthalidone and Cilnidipine in Combined Pharmaceutical Dosage Form. Research J. Pharm. and Tech 2020; 13(5):2376-2380. doi: 10.5958/0974-360X.2020.00427.8

Cite(Electronic):
Leena Sawaikar, Pankaj Kapupara. Development and Validation of a Stability indicating RP-HPLC Method for the Estimation of Chlorthalidone and Cilnidipine in Combined Pharmaceutical Dosage Form. Research J. Pharm. and Tech 2020; 13(5):2376-2380. doi: 10.5958/0974-360X.2020.00427.8   Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-5-57


REFERENCES:
1.    Sawicka K et al. Hypertension – The Silent Killer. Pre Clin and Clin Res. 2011;5(2):43–46.
2.    Tripathi KD. Essentials of Medical Pharmacology. Jaypee Brothers Medical Publishers Ltd., New Delhi. 2014
3.    Chamdra KS, Ramesh G, The fourth-generation Calcium channel blocker: Cilnidipine. Indian Heart J. 2013 Dec; 65(6): 691–695.
4.    Aishwarya PJ. Method Development and Validation for the Estimation of Telmisartan and Chlorthalidone in Bulk and Pharmaceutical Dosage form by HPTLC Method. Research J. Pharm. and Tech. 2015 April; 8(4): 376-81.
5.    Dagariya RK. Method Development and Validation of IrbesartanChlorthalidone and Cilnidipine in Their Combined Tablet Dosage Form By High Performance Liquid Chromatography. World J Pharm Pharm Sci. 2017;6(8):2504–18.
6.    Sonia K, Nappinnai M, Panneerselvam P. Stability indicating Method Development and Validation of Telmisartan and Ramipril by UV Spectrophotometry. Research J. Pharm. and Tech. 2018; 11(7): 3087-90.
7.    Vijaykumar TP et al. RP-HPLC Method for Simultaneous Estimation of Cilnidipine and Chlorthalidone. Research J. Pharm. and Tech. 2017; 10(11): 3990-96.
8.    Saravanan G, Praveen PN, Janeyulu IS, Visagaperumal D. Development and validation of stability indicating rp-hplc method for the simultaneous estimation of metoprolol succinate and cilnidipine in bulk and pharmaceutical dosage form. Int J Pharm Pharm Sci. 2015
9.    Sohan SC et al. A stability-indicating reverse phase high performance liquid chromatography method for the simultaneous determination of ramipril and valsartan in pharmaceutical dosage form. Research J. Pharm. and Tech. 2008;1(3):215-17.
10.    Krishnamurthy M. Cilnidipine in bulk and pharmaceutical dosage form by using RP-HPLC-. 2016;6(3):149–60.
11.    Bakshe PT. Development and Validation of RpHplc Method for the Simultaneous Estimation of Atenolol and Chlorthalidone in Tablet Formulation. World J Pharm Res. 2017;(June):897–907.
12.    Murali P, Sunil Kumar Chaitanya P, Pavani C, Rohini Reddy G, Ramalingam R. Development and validation of a stability-indicating RP-HPLC method for the simultaneous quantification of OlmesartanMedoxomil and Chlorthalidone in solid dosage form. Der Pharm Lett. 2014.
13.    Mohammed MS, Manohara YN. Development and validation of a Rapid Stability Indicating chromatographic determination of Cilnidipine in Bulk and Dosage form. Research J. Pharm. and Tech. 2013; 6(3): 296-99.
14.    Hussein LA, Magdy NN, Ibrahim MA. Stability-Indicating RP-UPLC Method for Simultaneous Determination of Azilsartan Medoxomil and Chlorthalidone in Tablets in the Presence of Its Degradation Products. J Chromatogr Sci. 2019.
15.    Chaudhary BR. Development and validation of stability indicating gradient rp-hplc method for simultaneous estimation of telmisartan and chlorthalidone in bulk api and fixed dose combination. World J Pharm Res. 2017.
16.    Kayesh R, Jahan MS, Sultan MZ. Development Using Response Surface Methodology and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Azilsartan Medoxomil and Chlorthalidone in Solid Dosage Form. Chromatographia. 2017.
17.    Raval H.V., Patel D.M., Patel C.N. Estimation of Metoprolol Tartrate and Chlorthalidone in Combined Dosage Form by UV-Spectrophotometric Methods. Research J. Pharm. and Tech. 2011; 4(7):1132-34.
18.    Sonawane S, Jadhav S, Rahade P, Chhajed S, Kshirsagar S. Development and Validation of Stability-Indicating Method for Estimation of Chlorthalidone in Bulk and Tablets with the Use of Experimental Design in Forced Degradation Experiments. Scientifica (Cairo). 2016.
19.    Celina Nazareth, Shefali Naik, Anwesha Dourado. Development and Validation of a simple and rapid RP-HPLC method for the simultaneous estimation of Amlodipine and Atorvastatin in Tablet Dosage Form. Research J. Pharm. and Tech. 2019; 12(4):1875-79.
20.    Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs - A review. J Pharm Anal [Internet]. 2014;4(3):159–65. Available from: http://dx.doi.org/10.1016/j.jpha.2013.09.003
21.    Poonam K. Significance of Stability Studies on Degradation Product. Research J. Pharm. and Tech. 2009; 2 (4):621-627.
22.    Sinha PK, Jeswani RM, Topgi KS, Damle MC. Stability Indicating RP-HPLC Method for Determination of Potassium Clavulanate in the presence of its Degradation Products. Research J. Pharm. and Tech. 2010;3(1): 141-145.
23.    Quadri SS, Sonwane L V, Poul BN, Kamshette SN. Review on Stability Indicating Assay Methods. (SIAMs ). 2014;2(8):16–31.
24.    Q2B Validation of Analytical Procedures.https://www. ich.org/products/guidelines/quality/article/quality-guidelines.html accessed (30th April 2019).

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available